BIPOLAR LEADS FOR USE WITH PERMANENTLY IMPLANTABLE CARDIAC PACING SYSTEMS - A REVIEW OF LIMITATIONS OF TRADITIONAL AND COAXIAL CONFIGURATIONS AND THE DEVELOPMENT AND TESTING OF NEW CONDUCTOR, INSULATION, AND ELECTRODE DESIGNS
Gfo. Tyers et al., BIPOLAR LEADS FOR USE WITH PERMANENTLY IMPLANTABLE CARDIAC PACING SYSTEMS - A REVIEW OF LIMITATIONS OF TRADITIONAL AND COAXIAL CONFIGURATIONS AND THE DEVELOPMENT AND TESTING OF NEW CONDUCTOR, INSULATION, AND ELECTRODE DESIGNS, Journal of investigative surgery, 10(1-2), 1997, pp. 1-15
The unacceptable rate of mechanical failures, threshold problems, and
recalls experienced with many coaxial bipolar cardiac pacing lead desi
gns are reviewed in detail. To address these problems, redundant insul
ation coradial atrial and ventricular tined leads (AL and VL, respecti
vely) with iridium oxide electrodes were developed and subjected to ex
tensive accelerated testing. There were no mechanical failures. The ne
w lead body design proved to be much more durable than widely used tri
filar MP35N configurations. The data reviewed and early and current te
st results are strongly supportive of tightly coupled insulation being
a major factor in improving lead durability as long as the insulating
material is not stressed. In addition to improving flex life, insulat
ion adherence to the conductor may reduce the potential for ionic degr
adation. Pacing and sensing thresholds in animal studies of the new le
ads were within the reported range for leads with steroid eluting elec
trodes. A multicenter Canadian clinical trial was initiated with the f
irst implant in early January 1994. By November 1995, 110 VL and 82 AL
had been placed in 124 patients and followed for a mean of 11 +/- 6 m
onths; maximum 21, total 1355. There were 60 males and 64 females with
a mean age of 64 +/- 16 years, range 15-88. Primary indications for p
acing were AV block in 61 patients, sick sinus syndrome in 53, vasovag
al syncope in 4, and congestive heart failure in 7. Many patients had
associated or primary tachyarrhythmias, including 111 with supraventri
cular and 12 with ventricular. Forty-two percent of patients (52/124)
had prior cardiac procedures, including 18 open heart surgeries and 20
AV nodal ablations. At implant, 8 lead characteristics were rated goo
d or excellent in 90% (746/829) of evaluations. X-ray visibility was o
f concern in 10% of patients (12/124). Three perioperative complicatio
ns occurred, including displacement of one AL (1.2%) and one VL (0.9%)
. There were no subsequent mechanical (connector, conductor, or insula
tion) or functional (exit block, micro or macro displacement, or over-
or undersensing) problems. Implant pacing thresholds (PT) at 0.45 ms
were AL, 0.6 +/- 0.2 (74) and VL 0.4 +/- 0.2 V; impedance (Z) at 3.5 V
output AL 373 +/- 77 (82) and VL 497 +/- 117 Ohm. sensing thresholds
(ST) were AL 3.1 +/- 1.6 (74) and VL 10.3 +/- 4.9 mV. Ventricular lead
data were obtained for all patients (N = 110). Atrial lead data are i
ncomplete, because some patients were in atrial fibrillation during im
plantation. After 12 months, AL PT at 1.5 V output was 0.18 +/- 0.10 m
s (21) and at 2.5 V was 0.10 +/- 0.05 (22). Associated AL ST was 3.3 /- 0.9 mV(21) and AL Z 500 +/- 65 Ohm (25). After 18 months VL PT at 1
.5 V was 0.15 +/- 0.10 ms (9) and at 2.5 V output was 0.09 +/- 0.04 ms
(9). Associated VL ST was >7.5 +/- 2.4 mV (9) and VL Z 497 +/- 105 Oh
m (9). Follow-up time discrepancy is due to the VL being available 6 m
onths earlier than the AL. There were no 30-day deaths and only one la
te death at 10 months in a patient with chronic atrial fibrillation. D
eath was unrelated to pacer or lead function. At 1 year, 68% AL (15/22
) and 62% VL (24/39) captured at 0.5 V and less than or equal to 1 ms
pulse width output. Innovative adherent insulation coradial bipolar le
ad conductors of the design studied combined with coated iridium oxide
electrodes provide for a negligible incidence of mechanical or functi
onal failure with clinical follow-up now approaching 3 years. Excellen
t acute and chronic sensing and pacing thresholds have been documented
. Late thresholds have continued to improve gradually. Long-term clini
cal pacing at less than or equal to 1. 5 V output with a large safety
margin is feasible in essentially all patients. This coradial design p
roduces very flexible <5 French bipolar redundantly insulated lead bod
ies allowing both AL and VL to simultaneously pass through a single 10
French introducer sheath. The coradial design reduces potential insul
ation, subclavian crush, and implant and late threshold problems versu
s coaxial approaches. Because the leads are so slender with reduced me
tallic content, some method of increasing radiopacity would help when
using older fluoroscopes that are standard in many Canadian centers.